HCPCS G9132
Oncology; disease status; prostate cancer, limited to adenocarcinoma; hormone-refractory/androgen-independent (e.g., rising psa on anti-androgen therapy or post-orchiectomy); clinical metastases (for use in a medicare-approved demonstration project)
Current code0 hospitals with prices
What Washington hospitals publish for this code
No Washington hospital publishes a dollar price for this code yet.
Medicare (traditional) reference
CMS publishes no national amount for this code.